Intrinsic value of LifePoint Health - LPNT

Previous Close

$64.93

  Intrinsic Value

$58.16

stock screener

  Rating & Target

hold

-10%

Previous close

$64.93

 
Intrinsic value

$58.16

 
Up/down potential

-10%

 
Rating

hold

We calculate the intrinsic value of LPNT stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 2.5

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  2.00
  2.30
  2.57
  2.81
  3.03
  3.23
  3.41
  3.57
  3.71
  3.84
  3.95
  4.06
  4.15
  4.24
  4.31
  4.38
  4.44
  4.50
  4.55
  4.59
  4.64
  4.67
  4.70
  4.73
  4.76
  4.78
  4.81
  4.83
  4.84
  4.86
Revenue, $m
  6,417
  6,565
  6,734
  6,923
  7,133
  7,363
  7,614
  7,885
  8,178
  8,492
  8,827
  9,186
  9,567
  9,972
  10,403
  10,859
  11,341
  11,851
  12,391
  12,960
  13,561
  14,194
  14,862
  15,566
  16,307
  17,087
  17,908
  18,772
  19,681
  20,638
Variable operating expenses, $m
  2,839
  2,900
  2,970
  3,049
  3,136
  3,231
  3,335
  3,447
  3,568
  3,698
  3,656
  3,804
  3,962
  4,130
  4,308
  4,497
  4,697
  4,908
  5,132
  5,368
  5,616
  5,879
  6,155
  6,447
  6,754
  7,077
  7,417
  7,775
  8,151
  8,547
Fixed operating expenses, $m
  3,343
  3,417
  3,492
  3,568
  3,647
  3,727
  3,809
  3,893
  3,979
  4,066
  4,156
  4,247
  4,341
  4,436
  4,534
  4,633
  4,735
  4,839
  4,946
  5,055
  5,166
  5,280
  5,396
  5,514
  5,636
  5,760
  5,886
  6,016
  6,148
  6,284
Total operating expenses, $m
  6,182
  6,317
  6,462
  6,617
  6,783
  6,958
  7,144
  7,340
  7,547
  7,764
  7,812
  8,051
  8,303
  8,566
  8,842
  9,130
  9,432
  9,747
  10,078
  10,423
  10,782
  11,159
  11,551
  11,961
  12,390
  12,837
  13,303
  13,791
  14,299
  14,831
Operating income, $m
  235
  248
  272
  306
  350
  405
  470
  545
  631
  727
  1,016
  1,134
  1,264
  1,406
  1,561
  1,728
  1,909
  2,104
  2,313
  2,538
  2,778
  3,036
  3,311
  3,604
  3,917
  4,250
  4,605
  4,981
  5,382
  5,807
EBITDA, $m
  708
  727
  758
  801
  855
  920
  997
  1,084
  1,183
  1,294
  1,416
  1,551
  1,698
  1,859
  2,032
  2,220
  2,423
  2,641
  2,875
  3,125
  3,393
  3,680
  3,985
  4,310
  4,657
  5,025
  5,417
  5,833
  6,274
  6,743
Interest expense (income), $m
  139
  157
  161
  166
  172
  178
  186
  194
  202
  212
  222
  233
  244
  257
  270
  284
  299
  315
  332
  349
  368
  388
  409
  431
  454
  478
  504
  531
  559
  589
  621
Earnings before tax, $m
  78
  87
  106
  134
  172
  219
  276
  343
  419
  505
  783
  890
  1,007
  1,136
  1,276
  1,429
  1,594
  1,772
  1,964
  2,170
  2,391
  2,627
  2,880
  3,151
  3,439
  3,746
  4,074
  4,422
  4,792
  5,186
Tax expense, $m
  21
  24
  29
  36
  46
  59
  75
  93
  113
  136
  211
  240
  272
  307
  345
  386
  430
  478
  530
  586
  645
  709
  778
  851
  929
  1,012
  1,100
  1,194
  1,294
  1,400
Net income, $m
  57
  64
  77
  98
  125
  160
  202
  250
  306
  369
  572
  650
  735
  829
  932
  1,043
  1,164
  1,293
  1,433
  1,584
  1,745
  1,918
  2,103
  2,300
  2,511
  2,735
  2,974
  3,228
  3,498
  3,786

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  6,411
  6,558
  6,727
  6,916
  7,126
  7,356
  7,606
  7,877
  8,170
  8,483
  8,819
  9,176
  9,558
  9,963
  10,392
  10,848
  11,330
  11,840
  12,378
  12,947
  13,547
  14,180
  14,847
  15,550
  16,290
  17,070
  17,890
  18,753
  19,662
  20,617
Adjusted assets (=assets-cash), $m
  6,411
  6,558
  6,727
  6,916
  7,126
  7,356
  7,606
  7,877
  8,170
  8,483
  8,819
  9,176
  9,558
  9,963
  10,392
  10,848
  11,330
  11,840
  12,378
  12,947
  13,547
  14,180
  14,847
  15,550
  16,290
  17,070
  17,890
  18,753
  19,662
  20,617
Revenue / Adjusted assets
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
  1.001
Average production assets, $m
  4,075
  4,169
  4,276
  4,396
  4,529
  4,676
  4,835
  5,007
  5,193
  5,392
  5,605
  5,833
  6,075
  6,333
  6,606
  6,895
  7,202
  7,526
  7,868
  8,230
  8,611
  9,013
  9,437
  9,884
  10,355
  10,850
  11,372
  11,920
  12,498
  13,105
Working capital, $m
  436
  446
  458
  471
  485
  501
  518
  536
  556
  577
  600
  625
  651
  678
  707
  738
  771
  806
  843
  881
  922
  965
  1,011
  1,058
  1,109
  1,162
  1,218
  1,277
  1,338
  1,403
Total debt, $m
  2,978
  3,073
  3,181
  3,303
  3,438
  3,586
  3,747
  3,921
  4,109
  4,310
  4,526
  4,756
  5,001
  5,262
  5,538
  5,831
  6,141
  6,469
  6,815
  7,181
  7,567
  7,974
  8,402
  8,854
  9,330
  9,832
  10,359
  10,914
  11,498
  12,112
Total liabilities, $m
  4,122
  4,217
  4,325
  4,447
  4,582
  4,730
  4,891
  5,065
  5,253
  5,455
  5,670
  5,900
  6,145
  6,406
  6,682
  6,975
  7,285
  7,613
  7,959
  8,325
  8,711
  9,118
  9,547
  9,999
  10,475
  10,976
  11,503
  12,058
  12,642
  13,257
Total equity, $m
  2,289
  2,341
  2,401
  2,469
  2,544
  2,626
  2,715
  2,812
  2,917
  3,028
  3,148
  3,276
  3,412
  3,557
  3,710
  3,873
  4,045
  4,227
  4,419
  4,622
  4,836
  5,062
  5,300
  5,551
  5,816
  6,094
  6,387
  6,695
  7,019
  7,360
Total liabilities and equity, $m
  6,411
  6,558
  6,726
  6,916
  7,126
  7,356
  7,606
  7,877
  8,170
  8,483
  8,818
  9,176
  9,557
  9,963
  10,392
  10,848
  11,330
  11,840
  12,378
  12,947
  13,547
  14,180
  14,847
  15,550
  16,291
  17,070
  17,890
  18,753
  19,661
  20,617
Debt-to-equity ratio
  1.300
  1.310
  1.320
  1.340
  1.350
  1.370
  1.380
  1.390
  1.410
  1.420
  1.440
  1.450
  1.470
  1.480
  1.490
  1.510
  1.520
  1.530
  1.540
  1.550
  1.560
  1.580
  1.590
  1.600
  1.600
  1.610
  1.620
  1.630
  1.640
  1.650
Adjusted equity ratio
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357
  0.357

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  57
  64
  77
  98
  125
  160
  202
  250
  306
  369
  572
  650
  735
  829
  932
  1,043
  1,164
  1,293
  1,433
  1,584
  1,745
  1,918
  2,103
  2,300
  2,511
  2,735
  2,974
  3,228
  3,498
  3,786
Depreciation, amort., depletion, $m
  472
  479
  487
  495
  505
  515
  527
  539
  552
  567
  400
  417
  434
  452
  472
  493
  514
  538
  562
  588
  615
  644
  674
  706
  740
  775
  812
  851
  893
  936
Funds from operations, $m
  530
  543
  564
  593
  630
  675
  728
  789
  858
  935
  972
  1,066
  1,169
  1,282
  1,404
  1,536
  1,678
  1,831
  1,995
  2,172
  2,360
  2,562
  2,777
  3,006
  3,250
  3,510
  3,786
  4,080
  4,391
  4,722
Change in working capital, $m
  9
  10
  11
  13
  14
  16
  17
  18
  20
  21
  23
  24
  26
  28
  29
  31
  33
  35
  37
  39
  41
  43
  45
  48
  50
  53
  56
  59
  62
  65
Cash from operations, $m
  521
  533
  553
  580
  616
  660
  711
  771
  838
  914
  949
  1,042
  1,143
  1,254
  1,374
  1,505
  1,645
  1,796
  1,959
  2,133
  2,319
  2,519
  2,731
  2,958
  3,200
  3,457
  3,730
  4,021
  4,329
  4,657
Maintenance CAPEX, $m
  -285
  -291
  -298
  -305
  -314
  -324
  -334
  -345
  -358
  -371
  -385
  -400
  -417
  -434
  -452
  -472
  -493
  -514
  -538
  -562
  -588
  -615
  -644
  -674
  -706
  -740
  -775
  -812
  -851
  -893
New CAPEX, $m
  -78
  -94
  -107
  -120
  -133
  -146
  -159
  -172
  -186
  -199
  -213
  -227
  -242
  -257
  -273
  -289
  -306
  -324
  -342
  -362
  -381
  -402
  -424
  -447
  -471
  -495
  -521
  -549
  -577
  -607
Cash from investing activities, $m
  -363
  -385
  -405
  -425
  -447
  -470
  -493
  -517
  -544
  -570
  -598
  -627
  -659
  -691
  -725
  -761
  -799
  -838
  -880
  -924
  -969
  -1,017
  -1,068
  -1,121
  -1,177
  -1,235
  -1,296
  -1,361
  -1,428
  -1,500
Free cash flow, $m
  157
  148
  148
  155
  169
  190
  218
  253
  295
  344
  351
  414
  485
  563
  649
  743
  846
  958
  1,079
  1,209
  1,350
  1,501
  1,663
  1,837
  2,023
  2,222
  2,434
  2,660
  2,900
  3,157
Issuance/(repayment) of debt, $m
  78
  95
  108
  122
  135
  148
  161
  174
  188
  202
  216
  230
  245
  260
  276
  293
  310
  328
  346
  366
  386
  407
  429
  452
  476
  501
  528
  555
  584
  614
Issuance/(repurchase) of shares, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  78
  95
  108
  122
  135
  148
  161
  174
  188
  202
  216
  230
  245
  260
  276
  293
  310
  328
  346
  366
  386
  407
  429
  452
  476
  501
  528
  555
  584
  614
Total cash flow (excl. dividends), $m
  236
  243
  256
  276
  304
  338
  379
  427
  483
  545
  566
  644
  730
  823
  925
  1,036
  1,156
  1,286
  1,425
  1,575
  1,736
  1,908
  2,092
  2,289
  2,499
  2,723
  2,961
  3,215
  3,484
  3,771
Retained Cash Flow (-), $m
  -46
  -53
  -60
  -68
  -75
  -82
  -89
  -97
  -104
  -112
  -120
  -128
  -136
  -145
  -153
  -163
  -172
  -182
  -192
  -203
  -214
  -226
  -238
  -251
  -264
  -278
  -293
  -308
  -324
  -341
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  190
  190
  196
  209
  229
  256
  290
  331
  379
  433
  447
  516
  594
  679
  772
  874
  984
  1,104
  1,233
  1,372
  1,522
  1,682
  1,854
  2,038
  2,235
  2,445
  2,668
  2,907
  3,160
  3,430
Discount rate, %
  8.30
  8.72
  9.15
  9.61
  10.09
  10.59
  11.12
  11.68
  12.26
  12.88
  13.52
  14.20
  14.91
  15.65
  16.43
  17.26
  18.12
  19.02
  19.97
  20.97
  22.02
  23.12
  24.28
  25.49
  26.77
  28.11
  29.51
  30.99
  32.54
  34.16
PV of cash for distribution, $m
  175
  161
  151
  145
  142
  140
  139
  137
  134
  129
  111
  105
  97
  89
  79
  68
  58
  48
  39
  30
  23
  17
  13
  9
  6
  4
  2
  2
  1
  1
Current shareholders' claim on cash, %
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

LifePoint Health, Inc., through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities. Its services include general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation services and pediatric services, and in some of its hospitals, the Company offers specialized services, such as open-heart surgery, skilled nursing, psychiatric care and neuro-surgery. It provides outpatient services, such as same-day surgery, laboratory, x-ray, respiratory therapy, imaging, sports medicine and lithotripsy.

FINANCIAL RATIOS  of  LifePoint Health (LPNT)

Valuation Ratios
P/E Ratio 21.3
Price to Sales 0.4
Price to Book 1.2
Price to Tangible Book
Price to Cash Flow 6
Price to Free Cash Flow 74.1
Growth Rates
Sales Growth Rate 22.1%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 45.5%
Cap. Spend. - 3 Yr. Gr. Rate 16.7%
Financial Strength
Quick Ratio 4
Current Ratio 0.1
LT Debt to Equity 132.7%
Total Debt to Equity 133.7%
Interest Coverage 2
Management Effectiveness
Return On Assets 3.4%
Ret/ On Assets - 3 Yr. Avg. 3.8%
Return On Total Capital 2.4%
Ret/ On T. Cap. - 3 Yr. Avg. 3.1%
Return On Equity 5.5%
Return On Equity - 3 Yr. Avg. 6.5%
Asset Turnover 1
Profitability Ratios
Gross Margin 35.4%
Gross Margin - 3 Yr. Avg. 36.2%
EBITDA Margin 11%
EBITDA Margin - 3 Yr. Avg. 12.4%
Operating Margin 3.2%
Oper. Margin - 3 Yr. Avg. 4.5%
Pre-Tax Margin 3.2%
Pre-Tax Margin - 3 Yr. Avg. 4.5%
Net Profit Margin 1.9%
Net Profit Margin - 3 Yr. Avg. 2.7%
Effective Tax Rate 35.6%
Eff/ Tax Rate - 3 Yr. Avg. 35.1%
Payout Ratio 0%

LPNT stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the LPNT stock intrinsic value calculation we used $6291.4 million for the last fiscal year's total revenue generated by LifePoint Health. The default revenue input number comes from 0001 income statement of LifePoint Health. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our LPNT stock valuation model: a) initial revenue growth rate of 2% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 8.3%, whose default value for LPNT is calculated based on our internal credit rating of LifePoint Health, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of LifePoint Health.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of LPNT stock the variable cost ratio is equal to 44.3%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $3271 million in the base year in the intrinsic value calculation for LPNT stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for LifePoint Health.

Corporate tax rate of 27% is the nominal tax rate for LifePoint Health. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the LPNT stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for LPNT are equal to 63.5%.

Life of production assets of 14 years is the average useful life of capital assets used in LifePoint Health operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for LPNT is equal to 6.8%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $2242.5 million for LifePoint Health - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 38.726 million for LifePoint Health is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of LifePoint Health at the current share price and the inputted number of shares is $2.5 billion.

RELATED COMPANIES Price Int.Val. Rating
CYH Community Heal 3.81 7.04  str.buy
UHS Universal Heal 127.85 135.61  hold
THC Tenet Healthca 23.83 33.79  hold
HCA HCA Healthcare 141.54 41.29  str.sell

COMPANY NEWS

▶ LifePoint shareholders OK merger, reject $120M in payments to execs   [Oct-29-18 03:34PM  American City Business Journals]
▶ LifePoint: 3Q Earnings Snapshot   [07:43AM  Associated Press]
▶ Completion of $9.9B deal leaves Nashville with one fewer public health care company   [Oct-11-18 01:42PM  American City Business Journals]
▶ Here's how much LifePoints CEO could be paid following company's sale   [Oct-01-18 01:14PM  American City Business Journals]
▶ Another giant of Nashville's health care industry is retiring   [08:32AM  American City Business Journals]
▶ Three Nashville execs named among the most influential in health care   [08:41AM  American City Business Journals]
▶ Stocks Move Slowly but Surely Higher   [Aug-21-18 09:15AM  Zacks]
▶ On heels of merger news, Brentwood hospital company buys Washington system   [Aug-06-18 02:30PM  American City Business Journals]
▶ LifePoint's $5.6B deal is all about lowering costs   [Jul-25-18 10:56AM  American City Business Journals]
▶ [$$] LifePoint Health Agrees to Apollo Buyout   [11:32AM  The Wall Street Journal]
▶ LifePoint Surges 40% on Report of Acquisition Talks   [Jul-20-18 06:11PM  TheStreet.com]
▶ LifePoint-owned hospital settles whistleblower lawsuit   [Jun-22-18 08:28AM  American City Business Journals]
▶ LifePoint: 1Q Earnings Snapshot   [07:16AM  Associated Press]
▶ Castleview Hospital Named Duke LifePoint Quality Affiliate   [Apr-03-18 11:57AM  Business Wire]
▶ LifePoint Health, Inc. to Host Earnings Call   [Feb-23-18 08:00AM  ACCESSWIRE]
▶ LifePoint reports 4Q loss   [07:19AM  Associated Press]
▶ LifePoint Health Facilities Recognized by March of Dimes   [Jan-09-18 11:48AM  Business Wire]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.